The largest database of trusted experimental protocols

Nexfin

Manufactured by Edwards Lifesciences
Sourced in Canada, United States

The Nexfin is a non-invasive medical device that continuously measures arterial blood pressure. It uses a finger cuff to detect changes in the volume of blood vessels and provides real-time monitoring of blood pressure.

Automatically generated - may contain errors

24 protocols using nexfin

1

Noninvasive Cardiovascular Monitoring Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Heart rate was measured using a three‐lead electrocardiograph (ECG). Beat‐to‐beat blood pressure (BP) was measured by the volume clamp method using a finger cuff (Nexfin, Edwards Lifesciences, Ontario, Canada). The cuff was placed on the right middle finger and referenced to the level of the heart using a height correct unit for BP correction. MAP was obtained by integration of the pressure curve divided by the duration of the cardiac cycle. This method has been shown to reliably measure the dynamic changes in beat‐to‐beat BP which correlate well with the intraarterial BP recordings and can be used to describe the dynamic relationship between BP and cerebral blood velocity (Omboni et al. 1993; Sammons et al. 2007).
+ Open protocol
+ Expand
2

Cardiovascular Autonomic Function in RA

Check if the same lab product or an alternative is used in the 5 most similar protocols
In the study cohort, during one single visit demographics, anthropometric data, smoking and alcohol status, medical history, RA medication history and current medication were obtained between 8:30 and 10 am, after patients had fasted for 8 to 10 h. Continuous heart rate (HR) and blood pressure (BP) measurements were obtained non-invasively using finger arterial pressure waveform recording of the left hand by Nexfin (Edwards Lifesciences, BMEYE B.V. Amsterdam, the Netherlands), a validated method to assess HRV parameters (Rang et al., 2004 (link), Prevoo et al., 1995 (link)). The recording session contained two parts: ten-minute period in supine (resting) position, and a ten-minute period of orthostatic stress in upright (active) position. Individuals were allowed to equilibrate to the positional change before data were collected, followed by assessment of RA disease activity (Disease Activity Score of 28 joints (DAS28) with erythrocyte sedimentation rate (ESR) (Prevoo et al., 1995 (link))) and a blood draw.
In the validation cohort we determined vital signs at yearly visits, including resting heart rate (RHR) in sitting position, using an automated monitor system. This measurement took place in non-fasting state either in the morning or the afternoon.
+ Open protocol
+ Expand
3

Noninvasive Cardiovascular Monitoring Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Heart rate (HR) was measured using a 5‐lead ECG. Beat‐to‐beat BP and cardiac output (CO) were measured by the volume‐clamp method using a finger cuff (Nexfin, Edwards Lifesciences, Ontario, Canada). The cuff was placed on the right middle finger and referenced to the level of the heart using a height correct unit for BP correction. MAP was obtained by integration of the pressure curve divided by the duration of the cardiac cycle. The volume‐clamp method has been shown to reliably index the dynamic changes in beat‐to‐beat BP which correlate well with the intra‐arterial BP recordings and can be used to describe the dynamic relationship between BP and cerebral blood velocity (Sammons et al. 2007; Omboni et al. 1993).
+ Open protocol
+ Expand
4

Hemodynamic Monitoring in Critical Care

Check if the same lab product or an alternative is used in the 5 most similar protocols
Blood pressure (BP) was continuously measured using a non-invasive volume clamp method (Nexfin, Edwards Lifesciences BMEYE, Amsterdam, the Netherlands). Left ventricular SV was estimated by a pulse contour method (Nexfin CO-trek, Edwards Lifesciences BMEYE, Amsterdam, the Netherlands) [24 (link), 25 (link)] and CO was SV times heart rate (HR). SV index (SVI) was the ratio of SV and body surface area [26 ]. SPV and PPV were calculated from the BP signal:
100×AmaxAmin(Amax+Amin)/2
with Amax/min equal to, respectively, systolic arterial pressure (SAP) and pulse pressure (PP; SAP minus diastolic arterial pressure (DAP)). PPV and SPV were calculated for each breath and averaged over 5 consecutive breaths.
Airway flow and pressure were measured using an Alveotest flowmeter (Jaeger, Würzburg, Germany), tidal volume (TV) was the integral of airway flow (expressed in mL per kg predicted body weight) and end-tidal CO2 (PetCO2) was measured by capnography (Tonocap, Datex-Ohmeda, Madison, USA). Signals were visually inspected for artefacts and 60-second intervals were used for offline analysis (Matlab R2007b, Mathworks Inc. MA, USA).
+ Open protocol
+ Expand
5

Hemodynamic Responses During Squat-Stand Maneuvers

Check if the same lab product or an alternative is used in the 5 most similar protocols
Height and body mass of all participants were measured (Table 1). Then, resting hemodynamics of all participants was recorded for 10 min in the supine position. Heart rate was measured by 5‐lead ECG and blood pressure was measured using arterial volume clamping (Nexfin, Edwards Lifesciences, Ontario, Canada) on the middle finger of the right hand. MCAv was monitored with a 2 MHz pulsed transcranial Doppler ultrasound (Doppler Box, Compumedics DWL USA, Inc.). End‐tidal partial pressure of carbon dioxide (PETCO2) was recorded by a gas analyzer (Breezesuite, MedGraphics Corp.) during baseline rest and repeated squat‐stand maneuvers. The gas analyzer was calibrated according to the manufacturer's instructions before each measurement.
+ Open protocol
+ Expand
6

Cardiovascular Measurements During Rest

Check if the same lab product or an alternative is used in the 5 most similar protocols
Heart rate (HR) was recorded via continuous three-lead electrocardiogram, and systemic blood pressure was assessed (beat-to-beat) via finger plethysmography (Nexfin; Edwards Lifesciences, Irvine, CA) on the nonexercising hand. Brachial artery pressure was measured in duplicate using an automated cuff (Cardiocap/5, Datex-Ohmeda, Louisville, CO) prior to beginning exercise trials while the subjects were in a supine position following 15 min of rest.
+ Open protocol
+ Expand
7

Non-invasive Cardiovascular Monitoring

Check if the same lab product or an alternative is used in the 5 most similar protocols
A non-invasive SV monitor, the Nexfin (Edwards Lifesciences), was used throughout the study and synchronized with the carotid Doppler monitor for each cardiac cycle. Alignment of the Doppler spectrograms to the non-invasive SV monitor was performed by cross-correlating heart rate (HR) to find the optimal lag in the Doppler signal. Systolic, diastolic and mean arterial pressure were also obtained from the Nexfin.
+ Open protocol
+ Expand
8

Noninvasive Hemodynamic Monitoring During Physiological Challenges

Check if the same lab product or an alternative is used in the 5 most similar protocols
Continuous blood pressure (BP) was measured noninvasively by finger plethysmography with the cuff placed around the middle phalanx of the nondominant hand placed at heart level (Nexfin, Edwards Lifesciences BMEYE, the Netherlands). Left ventricular stroke volume (SV) was estimated beat by beat by pulse contour (Nexfin CO‐trek, Edwards Lifesciences BMEYE, Amsterdam, the Netherlands) and by inert gas rebreathing (Innocor, Innovision A/S, Odense, Denmark) (Gabrielsen et al. 2002; Bartels et al. 2011). CO was stroke volume (SV) times heart rate (HR). Total peripheral resistance (TPR) was the ratio of mean arterial pressure (BPmean) and CO. End‐tidal CO2 partial pressure (PetCO2) was monitored through a nasal cannula connected to a sampling capnograph (Datex Normocap 200, Helsinki, Finland).
Changes in MCAV were followed in the proximal segment of the middle cerebral artery (MCA) by transcranial Doppler ultrasonography (TCD; DWL Multidop X4, Sipplingen, Germany). The left MCA was insonated through the temporal window just above the zygomatic arch at a depth of 40–60 mm with a pulsed 2 MHz probe. Once the optimal signal‐to‐noise ratio was obtained, the probe was immobilized by a head band.
+ Open protocol
+ Expand
9

Continuous Noninvasive Blood Pressure Monitoring

Check if the same lab product or an alternative is used in the 5 most similar protocols
Seated BP was measured in triplicate using standard technique. Beat-to-beat arterial BP was measured continuously and noninvasively using digital pulse photoplethysmography12 (link), 13 (link) (NexFin, Edwards LifeSciences, Irvine, CA).
+ Open protocol
+ Expand
10

Endothelium-Dependent Vascular Reactivity Assessment

Check if the same lab product or an alternative is used in the 5 most similar protocols
Venous occlusion plethysmography (EC-6, D.E. Hokanson Inc. Indianapolis, IN) was used to determine endothelium-dependent reactivity in the left forearm and left calf (14 ). Baseline blood flow was measured by inflating the distal cuff (wrist or ankle) to a supra-systolic pressure (220 mmHg) then cyclically inflating the respective proximal cuff (upper arm or thigh) to 60 mmHg every 15 seconds for two minutes. Baseline blood flow was the average of all eight cycles. Following baseline, circulation to the experimental limb was arrested for five minutes by rapidly inflating the proximal cuffs to 240 mmHg inducing ischemia. Peak blood flow (BFPeak) was the highest measurement observed following deflation (reactive hyperemia). Total blood flow (BFTotal) for three minutes after cuff release was recorded and was defined as the area under the curve using the trapezium rule (28 (link)). Vascular conductance served as a surrogate of vasodilatory capacity and calculated as blood flow/mean arterial pressure (Nexfin, Edwards Lifesciences Irvine, CA). Peak and total vascular conductance (VCPeak and VCTotal, respectively) were determined in the same fashion as BFPeak and BFTotal, respectively. Blood pressure and plethysmography data were collected at 250 Hz and analyzed offline (WinDaq, DATAQ Instruments Akron, OH).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!